Tonix Pharmaceuticals Holding Stock In The News

TNXP Stock  USD 0.24  0.01  4.35%   
Our overall analysis of Tonix Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Tonix Pharmaceuticals Holding. The specific impact of Tonix Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tonix Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tonix Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tonix Pharmaceuticals Backtesting and Tonix Pharmaceuticals Hype Analysis.

Tonix Pharmaceuticals Today Top News and Investor Outlook

Yahoo News
7 F-Rated Stocks To Sell in July
https://finance.yahoo.com/news/7-f-rated-stocks-sell-110000086.html
 Bullish
Yahoo News
20 Countries With The Highest Number of Drug Trafficking in the World
https://finance.yahoo.com/news/20-countries-highest-number-drug-220037331.html
 Neutral
Yahoo News
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmyaâ„¢ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-conditional-acceptance-120000304.html
 Neutral
Yahoo News
Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US
https://finance.yahoo.com/news/best-drug-alcohol-rehab-centers-223154074.html
 Bullish
Yahoo News
Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-kol-webinar-120000926.html
 Neutral
Yahoo News
Tonix Study Reveals Promising Fibromyalgia Treatment
https://finance.yahoo.com/news/tonix-study-reveals-promising-fibromyalgia-202858930.html
 Bullish
Yahoo News
TNXP: Positive Results for Phase 3 RESILIENT Trial Sets Up NDA Filing in 2H24…
https://finance.yahoo.com/news/tnxp-positive-results-phase-3-141900108.html
 Bullish
Yahoo News
Tonix Pharmaceuticals Presents Additiona...
https://finance.yahoo.com/news/tonix-pharmaceuticals-presents-additional-data-120000219.html
 Neutral
Yahoo News
Tonix Pharmaceuticals to Present at Two ...
https://finance.yahoo.com/news/tonix-pharmaceuticals-present-two-upcoming-120000774.html
 Neutral
Yahoo News
Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-key-topline-110829443.html
 Bullish

Tonix Pharmaceuticals Holding Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tonix and other traded companies coverage with news coverage. We help investors stay connected with Tonix headlines for the 18th of January 2025 to make an informed investment decision based on correlating the impacts of news items on Tonix Stock performance. Please note that trading solely based on the Tonix Pharmaceuticals Holding hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tonix Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Tonix Pharmaceuticals Holding investors visualize upcoming and past events in order to time the market based on Tonix Pharmaceuticals Holding noise-free hype analysis.
Tonix Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Tonix earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Tonix Pharmaceuticals that are available to investors today. That information is available publicly through Tonix media outlets and privately through word of mouth or via Tonix internal channels. However, regardless of the origin, that massive amount of Tonix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tonix Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tonix Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tonix Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tonix Pharmaceuticals alpha.

Tonix Largest EPS Surprises

Earnings surprises can significantly impact Tonix Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-13
2024-03-31-0.39-0.180.2153 
2022-08-08
2022-06-30-1.44-1.220.2215 
2023-03-13
2022-12-31-0.86-0.560.334 
2022-03-14
2021-12-31-1.92-2.24-0.3216 
2022-11-07
2022-09-30-1.02-0.690.3332 
2023-11-09
2023-09-30-1.49-1.83-0.3422 
View All Earnings Estimates

Tonix Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Tonix Pharmaceuticals Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
15th of January 2025
Tonix Pharmaceuticals Holding 9-Day RSI NA - GuruFocus.com
at news.google.com 
Gurufocus Stories at Macroaxis
8th of January 2025
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of G...
at gurufocus.com 
seekingalpha News
23rd of December 2024
Tonix gets FDA target action date for TNX-102 SL
at seekingalpha.com 
benzinga news
18th of December 2024
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22 Here Are 20 Stocks Movin...
at benzinga.com 
seekingalpha News
17th of December 2024
Tonix stock jumps on FDA review for pain drug
at seekingalpha.com 
Macroaxis News: globenewswire.com
16th of December 2024
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlig...
at globenewswire.com 
news
9th of December 2024
Tonixs TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia S...
at newswire.com 
news
14th of November 2024
Tonix Pharmaceuticals Now Covered by StockNews.com
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tonix Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tonix Pharmaceuticals' short interest history, or implied volatility extrapolated from Tonix Pharmaceuticals options trading.

Additional Tools for Tonix Stock Analysis

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.